Skip to content

analgesic effect of intranasal ketamine in patients with renal colic

Comparison of analgesic effect of intranasal ketamine and intravenous morphine in patients with renal colic

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201412208872N8
Enrollment
50
Registered
2015-01-18
Start date
2015-01-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urolithiasis. Calculus of kidney and ureter

Interventions

Intervention 1: Group 1: receive 1 mg/kg intranasal ketamin as analgesic and intravenous sodium chloride solution as placebo. We use 0.75mcg/kg fentanyl as rescue analgesic if, 1- persistent pain afte
Treatment - Drugs
Group 1: receive 1 mg/kg intranasal ketamin as analgesic and intravenous sodium chloride solution as placebo. We use 0.75mcg/kg fentanyl as rescue analgesic if, 1- persistent pain after 30 min 2- chan
group2, receive 0.1 mg/kg intravenous morphine as analgesic and intranasal sodium chloride solution as placebo. We use 0.75mcg/kg fentanyl as rescue analgesic if, 1- persistent pain after 30 min 2- ch

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patient with high clinical suspicious of renal colic; all patient who come with pain and have clinical or lab data of renal colic. Exclusion criteria: age < 15 years; unwilling to study participation; past history of allergy to morphine or ketamine; pregnancy; history of analgesic drug consumption < 6 hours ago; peritoneal sign; liver; renal or heart failure patients; decrease level of consciousness; mental disability

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain due to urolithiasis. Timepoint: 0, 15, 30 min. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Side effects. Timepoint: during discharge. Method of measurement: quessionary.;Patients satisfaction. Timepoint: during discharge. Method of measurement: quessionary.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Morteza Saeedi

Tehran University of Medical Sciences

m_saeedi@tums.ac.ir+98 21 8490 2719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026